BACAX
Price
$17.26
Change
+$0.05 (+0.29%)
Updated
Jul 10 closing price
Net Assets
339.4M
VGENX
Price
$57.10
Change
+$0.21 (+0.37%)
Updated
Jul 10 closing price
Net Assets
6.91B
Interact to see
Advertisement

BACAX vs VGENX

BACAX vs VGENX Comparison Chart in %
View a ticker or compare two or three
VS
BACAX vs. VGENX commentary
Jul 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BACAX is a Buy and VGENX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VGENX has more cash in the bank: 6.91B vs. BACAX (339M). VGENX pays higher dividends than BACAX: VGENX (2.84) vs BACAX (2.07). BACAX was incepted earlier than VGENX: BACAX (21 years) vs VGENX (42 years). BACAX (1.31) is less costly to investors than VGENX (0.45). BACAX is a more actively managed with annual turnover of: 66.00 vs. VGENX (19.00). BACAX has a lower initial minimum investment than VGENX: BACAX (1000) vs VGENX (3000). BACAX annual gain was more profitable for investors over the last year : 28.13 vs. VGENX (17.34). BACAX return over 5 years is better than : 131.71 vs. VGENX (56.68).
BACAXVGENXBACAX / VGENX
Total Expense Ratio1.310.45291%
Annual Report Gross Expense Ratio1.310.45291%
Fund Existence21 years42 years-
Gain YTD23.81615.028158%
Front Load5%N/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets339M6.91B5%
Annual Yield % from dividends2.072.8473%
Returns for 1 year28.1317.34162%
Returns for 3 years48.2922.95210%
Returns for 5 years131.7156.68232%
Returns for 10 years103.8614.29727%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NMRA1.680.03
+1.82%
Neumora Therapeutics
DXC9.320.06
+0.65%
DXC Technology Company
PG147.040.19
+0.13%
Procter & Gamble Company
LNTH105.64-0.35
-0.33%
Lantheus Holdings
TOON0.60-0.04
-6.33%
Kartoon Studios